| Emily Virginia Anne Finlayson, MD | |
|
2330 Post St, San Francisco, CA 94115-3465 | |
| (415) 885-3625 | |
| Not Available |
| Full Name | Emily Virginia Anne Finlayson |
|---|---|
| Gender | Female |
| Speciality | Colorectal Surgery (proctology) |
| Experience | 27 Years |
| Location | 2330 Post St, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083714802 | NPI | - | NPPES |
| 4800737 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | A68290 (California) | Secondary |
| 208C00000X | Colon & Rectal Surgery | A68290 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ucsf Dept Of Surgery | 7719886373 | 156 |
News Archive
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."
AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.
Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Excess consumption of phosphate over-activates nerves that raise blood pressure, leading to abnormally high blood pressure, a new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports.
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."
AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.
Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Excess consumption of phosphate over-activates nerves that raise blood pressure, leading to abnormally high blood pressure, a new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports.
› Verified 2 days ago
| Entity Name | Ucsf Dept Of Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477627537 PECOS PAC ID: 7719886373 Enrollment ID: O20040102000839 |
News Archive
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."
AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.
Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Excess consumption of phosphate over-activates nerves that raise blood pressure, leading to abnormally high blood pressure, a new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports.
› Verified 2 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."
AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.
Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Excess consumption of phosphate over-activates nerves that raise blood pressure, leading to abnormally high blood pressure, a new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Virginia Anne Finlayson, MD 2330 Post St, San Francisco, CA 94115-3465 Ph: (415) 885-3625 | Emily Virginia Anne Finlayson, MD 2330 Post St, San Francisco, CA 94115-3465 Ph: (415) 885-3625 |
News Archive
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."
AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.
Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Excess consumption of phosphate over-activates nerves that raise blood pressure, leading to abnormally high blood pressure, a new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology reports.
› Verified 2 days ago